首页> 外文期刊>Pediatric nephrology: journal of the International Pediatric Nephrology Association >Peritoneal protein losses in children with steroid-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis.
【24h】

Peritoneal protein losses in children with steroid-resistant nephrotic syndrome on continuous-cycler peritoneal dialysis.

机译:连续骑自行车腹膜透析患类固醇抵抗性肾病综合征儿童的腹膜蛋白质损失。

获取原文
获取原文并翻译 | 示例
           

摘要

Glomerular protein permeability rises in nephrotic syndrome and may result from the effect of an unidentified "circulating factor." The effect of this "circulating factor" on the permeability of other body membranes is unknown. In this study we examine the peritoneal membrane protein permeability in patients with nephrotic syndrome on chronic-cycler peritoneal dialysis. We conducted a retrospective study of peritoneal protein losses in the dialysate effluent of 60 pediatric peritoneal dialysis patients (ages 5.1-22 years) over a 6-year period (January 1997-December 2002). Nineteen patients had steroid-resistant nephrotic syndrome (SRNS), while 41 had other non-nephrotic etiologies of renal failure. Total and normalized peritoneal protein losses are higher in SRNS than in non-nephrotic patients (12,603+/-5,403 mg/day vs 4,475+/-469 mg/day, P<0.05; 297.8+/-79.3 mg/kg per day vs 156.8+/-16.0 mg/kg per day, P<0.05; 9,614.6+/-3,253.4 mg/m(2) per day vs 4,168.3+/-367.3 mg/m(2) per day, P<0.05). The ratio of total protein in dialysate to plasma, a measure of peritoneal membrane protein permeability, was higher in SRNS patients (3.50+/-1.00% vs 0.68+/-0.06%, P<0.001). Serum albumin concentration was lower in SRNS patients (3.09+/-0.13 mg/dl vs 3.52+/-0.07 mg/dl, P<0.01). There were no differences between the two groups with regard to duration of peritoneal dialysis, dialysis prescription, numbers of peritonitis episodes, catheter replacements, or hospitalizations. In summary, these results demonstrate that peritoneal protein losses in patients with SRNS are twice as great as in those without nephrotic syndrome. These results are consistent with the systemic effect of a "circulating factor" in SRNS and underscore the importance of adequate protein intake in patients on peritoneal dialysis.
机译:在肾病综合征中,肾小球蛋白的通透性增加,可能是由于未知的“循环因子”的作用所致。这种“循环因子”对其他体膜通透性的影响尚不清楚。在这项研究中,我们通过慢性骑行者腹膜透析检查了肾病综合征患者的腹膜蛋白渗透性。我们进行了一项回顾性研究,研究了6年(1997年1月至2002年12月)期间60例小儿腹膜透析患者(年龄5.1-22岁)的透析液中腹膜蛋白损失的情况。 19名患者患有类固醇抵抗性肾病综合征(SRNS),而41例患有其他非肾病性肾衰竭病因。 SRNS的总和正常腹膜蛋白损失高于非肾病患者(12,603 +/- 5,403 mg /天vs 4,475 +/- 469 mg /天,P <0.05; 297.8 +/- 79.3 mg / kg每天vs每天156.8 +/- 16.0 mg / kg,P <0.05;每天9,614.6 +/- 3,253.4 mg / m(2)与每天4,168.3 +/- 367.3 mg / m(2),P <0.05)。 SRNS患者中透析液与血浆中总蛋白的比例较高,这是衡量腹膜蛋白渗透性的指标(3.50 +/- 1.00%对0.68 +/- 0.06%,P <0.001)。 SRNS患者的血清白蛋白浓度较低(3.09 +/- 0.13 mg / dl对比3.52 +/- 0.07 mg / dl,P <0.01)。两组之间在腹膜透析持续时间,透析处方,腹膜炎发作次数,导管更换或住院方面无差异。总之,这些结果表明,SRNS患者的腹膜蛋白损失是没有肾病综合征患者的两倍。这些结果与SRNS中“循环因子”的全身作用一致,并强调了腹膜透析患者摄入足够蛋白质的重要​​性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号